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The tandem endocytic receptors megalin and cubilin are im- ated endocytosis initiated by the binding of filtered li-
portant proteins in renal pathology. The molecular mechanisms gands to receptors at the luminal surface, followed by
controlling proximal tubule reabsorption of proteins have been the clustering of these receptors into clathrin-coated pitsmuch elucidated in recent years. Megalin and cubilin constitute
at base of the microvilli. The coated pits are formedtwo important endocytic receptor proteins involved in this pro-
and pinched off by a process involving clathrin, adaptorcess. Although structurally very different the two receptor pro-
teins interact to mediate the reabsorption of a large number of proteins and other intracellular proteins giving rise to
filtered proteins, including carrier proteins important for trans- the endocytic vesicles or endosomes. Due to the action
port and cellular uptake of several vitamins, lipids and other of proton pumps the interior of these vesicles is acidifiednutrients. Dysfunction of either protein results in tubular pro-
causing dissociation of ligands from the receptors. Theteinuria and is associated with specific changes in vitamin me-
receptors recycle back to the luminal surface for repeatedtabolism due to the defective proximal tubular reabsorption of
carrier proteins. Additional focus on the two receptors is attracted binding of ligands whereas most ligands are processed
by the possible pathogenic role of excessive tubular protein up- further. Protein ligands generally are degraded by lyso-
take during conditions of increased filtration of proteins, and
somal enzymes, however, other ligands, such as vitamins,by recent findings implicating members of the low density lipo-
may be modified and/or released to the circulation atprotein-receptor family, which includes megalin, in the trans-
duction of signals by association with cytoplasmic proteins. basolateral cell surface.
Accumulating evidence suggests that the process of
tubular protein reabsorption not only reduces the overall
The kidney proximal tubule has a high capacity for protein content of the final urine, but also provides the
uptake of filtered proteins whether these are small pro- targeted uptake of specific substances serving essential
teins normally allowed to pass the glomerular filtration functions within the kidney and other tissues. This includes
barrier or are filtered due to glomerular dysfunction. The the recovery of several vitamins filtered in complex with
cut off molecular weight for filtration of plasma proteins carrier proteins. Furthermore, the accelerated tubular
during normal conditions has generally been assumed to reabsorption of specific proteins is implicated in the pro-
be in the range of 60 kD, that is, corresponding approxi- gression of chronic renal disease characterized by protein-
mately to the molecular weight of serum albumin. How- uria. Thus, focus is attracted toward the mechanisms that
ever, the diversity of proteins filtered is large and also mediate and regulate the proximal tubule uptake of pro-
includes relatively large proteins such as transferrin tein. The two large membrane-associated proteins mega-
(81 kD). Thus, the molecular apparatus for handling the lin and cubilin serve as endocytic receptors mediating the
reabsorption of these proteins must include the ability luminal uptake of a large number of proteins, including
to recognize a large number of different proteins and at albumin, which are filtered both in the normal glomeruli
the same time provide for an efficient uptake. The initial and as a result of glomerular dysfunction. They play an
step in the reuptake of proteins involves receptor medi- important role in the uptake of filtered carrier proteins
such as vitamin D binding protein, retinol binding pro-
tein, transcobalamin and transferrin, which minimizesKey words: LDL-receptor family, endocytosis, RAP, Fanconi syn-
drome, Imerlund-Gra¨sbeck syndrome, DBP. urinary losses of the corresponding vitamins and iron,
and provides substrate for renal metabolism of theseReceived for publication December 12, 2001
substances, notably the renal activation of vitamin D.and in revised form March 7, 2002
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Fig. 1. Structure of megalin (right) and cubilin
(left). Megalin is an 4,600 amino acid trans-
membrane protein with a non-glycosylated mo-
lecular weight of 517 kD. The extracellular
domain contains four cysteine-rich clusters of
low-density lipoprotein (LDL)-receptor type A
repeats constituting the ligand binding regions
separated by endothelial growth factor (EGF)
precursor homology domains containing YWTD
repeats responsible for the pH-dependent re-
lease of ligands [1–3]. The second cysteine-rich
cluster has been identified as binding region
for several ligands including receptor associated
protein (RAP) [4]. However, RAP is probably
binding to several binding regions on megalin.
The cytoplasmic tail contains three NPXY se-
quences mediating the binding to adaptor pro-
teins and the clustering into coated pits. In addi-
tion, these motifs may be involved in apical
sorting of the receptor (abstract; Takeda et al,
J Am Soc Nephrol 12:60A, 2001) and serve sig-
naling functions. Also, the cytoplasmic domain
contains several Src homology 3 and one Src
homology 2 recognition sites. Cubilin is an
3,600 amino acid protein with no transmem-
brane domain and a non-glycosylated molecular
weight of 400 kD [5–7]. The extracellular do-
main contains 27 CUB domains probably consti-
tuting molecular basis for the interaction with
multiple other proteins, as the binding site for
intrinsic factor-cobalamin and albumin has been
located within CUB domain 5-8 [8–10], whereas
the binding site for RAP is located within CUB
domain 13-14 [9]. The CUB domains are pre-
ceded by a stretch of 110 amino acids followed
by 8 EGF-type repeats. The initial amino acids
stretch contains a furin cleavage site that may
indicate proteolytic processing in the trans-
Golgi network. The amino terminal region con-
tains a potential palmitoylation site [11] and an
amphipatic -helix structure with some similar-
ity to the lipid binding regions of apolipopro-
teins. This N-terminal region also may be in-
volved in the binding of intrinsic factor-vitamin
B12 (IF-B12) and albumin [10] and megalin [12].
Both are potential contributors to the anchoring
of the receptor in the membrane [9]. Electron
microscopy and sequence analysis have sug-
gested that cubilin may form trimers by non-
covalent interaction between -helices [13].
on their involvement in normal proximal tubule protein plasmic tail appears to be involved in apical sorting of
the receptor (abstract; Takeda et al, J Am Soc Nephrolreabsorption as well as their implication in renal patho-
12:60A, 2001) and serve signaling functions [14]. Both thephysiology.
rat [2] and human megalin gene [3] have been cloned,
the latter being located to chromosome 2q24-q31.
MOLECULAR CHARACTERISTICS OF Cubilin, which is identical to the intestinal intrinsic
MEGALIN AND CUBILIN factor receptor, is an approximately 460 kD glycoprotein
Megalin is an approximately 600 kD glycoprotein and with no transmembrane domain (Fig. 1) [5–7]. It has little
a member of the low-density lipoprotein (LDL)-receptor structural homology with other known endocytic recep-
family (Fig. 1). It has a single transmembrane domain tors, and does not harbor any obvious sites for interaction
and a large N-terminal extracellular domain dominated with adaptor proteins or other mediators of clathrin
by four clusters of low-density lipoprotein-receptor type coated endocytosis. The extracellular domain is domi-
A repeats constituting the ligand binding regions [2, 3]. nated by 27 complement subcomponents, the C1r/C1s,
The cytoplasmic tail contains sequences believed to me- Uegf, and bone morphogenic protein-1 (CUB) domains
giving name to the receptor and believed to constitutediate endocytosis of the receptor. In addition, the cyto-
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of the small intestine [20, 21], and the placenta [22–24].
In addition, megalin is expressed in the choroid plexus,
ependymal cells, epididymis, oviduct, thyroid cells, laby-
rinthic cells of the inner ear, type II pneumocytes, the
parathyroid hormone (PTH) secreting cells of the para-
thyroid gland, the endometrium, the ciliary epithelium
of the eye, and embryonic tissues such as the trophoec-
todermic cells and the neuroectoderm [23] reviewed in
[18]. The expression of cubilin at present appears more
restricted, although the receptor has been identified in
other tissues including thymus [22].
The normal expression of megalin is dependent on
receptor associated protein (RAP) [25] serving as a chap-
erone protecting newly synthesized receptor from the
early binding of ligands and possibly involved in folding
of the receptor [26–30]. RAP binds megalin with high
affinity within the rough endoplasmic reticulum (RER)
and functions as an intracellular ligand inhibiting the bind-
ing of most other ligands to megalin. RAP also binds
other members of the LDL-receptor family with a similar
function. Since RAP specifically inhibits binding to meg-
alin it serves as an important tool for the study of megalin
function. RAP also binds to cubilin [20], although its
role for the post-translational processing of this receptor
is unknown. It has been shown that a canine disorder
characterized by defective trafficking of cubilin into the
apical membranes is not caused by a defect in the cubilin
gene [7]. Rather, it was suggested that an as yet unknown
accessory protein is required for cubilin brush border
Fig. 2. Immunolabeling for megalin (10 nm gold particles) and cubilin expression, although the nature of this protein needs to
(5 nm gold particles; arrowheads) on an ultrathin cryosection from rat be established. Human cubilin appears to be truncatedproximal tubule. The receptors are co-expressed on microvilli, in apical
at a cleavage site for furin in the N-terminal region, sug-coated pits, in dense apical tubules (DAT), in endosomes (E) and in
a dense apical tubule detaching from the endosomal membrane (arrow). gesting that processing of cubilin may involve furin-
Magnification 105,000. mediated cleavage in the trans-Golgi network [6].
INTERACTION BETWEEN MEGALIN
the ligand binding domains. The amino terminal region AND CUBILIN
seems essential for the anchoring of the protein in the
A high affinity, Ca2-dependent and partially RAP-membrane. The complete DNA sequences of rat [5], canine
inhibitable binding between purified cubilin and megalin[7], and human [6] cubilin have been identified and the
has been described in vitro [5]. Since cubilin itself haslatter gene has been located to chromosome 10p12.33-p13.
no obvious sites for interaction with adaptor proteins or
other mediators of clathrin coated endocytosis, it has
EXPRESSION OF MEGALIN AND CUBILIN been hypothesized that megalin mediates the endocyto-
sis and intracellular trafficking of cubilin [5]. This is fur-The renal expression of megalin and cubilin is confined
ther supported by studies showing that the in vitro up-to the proximal tubules [15] with some additional expres-
take of the cubilin ligands transferrin, Clara cell secretorysion of megalin in the glomerular podocytes of rats [16].
protein, and apolipoprotein A-I (apo A-I)/high-densityBoth receptors are highly expressed in the luminal plasma
lipoprotein (HDL) is inhibited by anti-megalin antibod-membrane, including microvilli, as well as the proximal
ies [31–33] as well as by megalin anti-sense oligonucleo-tubule apical endocytic apparatus including apical coated
tides [22]. Furthermore, in megalin deficient mice trans-pits, endosomes, the lysosomal matrix, and in dense api-
ferrin accumulates on the luminal membrane of thecal tubules (DAT) constituting the membrane recycling
proximal tubule cells without being internalized [31].vehicle (Fig. 2) [17, 18]. The two receptors also colocalize
In addition to direct receptor interaction megalin andin several extrarenal tissues, in particular absorptive epi-
theliums such as the visceral yolk sac [19], the epithelium cubilin share some ligands, including vitamin D binding
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Table 1. Ligands to megalin and cubilin moglobin, 2- and 1-microglobubin, immunoglobulin (Ig)
light chains, apolipoprotein H, lysozyme, cytochrome cMegalin Cubilin
and -amylase. Many of these proteins, including DBP,Vitamin binding proteins
Transcobalamin-vitamin B12 [36] Intrinsic factor-vitamin B12 [37] RBP, 2-microglobin and 1-microglobulin, are recog-
Vitamin D binding protein [38] Vitamin D binding protein [34] nized urinary markers of tubular dysfunction suggesting
Retinol binding protein [39]
that megalin and cubilin are essential to normal tubularApolipoproteins
Apolipoprotein B [40] Apolipoprotein A-I [32] protein reabsorption. Most ligands bind in a calcium
Apolipoprotein E [41] HDL [42] dependent fashion possibly involving stretches of basic
Apolipoprotein J/clusterin [43]
amino acids [59]. Interestingly, megalin also binds poly-Apolipoprotein H [44]
Low molecular weight peptides basic drugs including aminoglycosides, and polymyxin B
and hormones possibly being involved in the nephro- and ototoxicity
PTH [45]
displayed by these agents [59].Insulin [46]
2-microglobulin [46] Several ligands for megalin have been identified from
Epidermal growth factor [46] studies of megalin deficient mice. These mice, produced
Prolactin [46]
by gene targeting, exhibit severe forebrain abnormalitiesLysozyme [46]
Cytochrome c [46] and lung defects [64]. Most of them die perinatally, how-
1-microglobulin [47] ever, approximately two percent survive to adulthood
PAP-1 [47]
constituting a model for the study of megalin function.Odorant-binding protein [47]
Transthyretin [48] The gross structure of the kidney from these mice is
Other normal, however, ultrastructurally the proximal tubule
Albumin [49] Albumin [35]
cells are characterized by a loss of endocytic invagi-RAP [41, 50–53] RAP [20]
Ig light chains [54] Ig light chains [55] nations, vesicles and DATs [64, 65]. Likely this reflects
Hemoglobin [56] Hemoglobin [56] a decreased endocytic activity and supports an important
Plasminogen [57] Transferrin [31]
role of megalin for proximal tubule endocytic activity.Lactoferrin [41] Clara cell secretory
Thyroglobulin [58] protein [33] The megalin deficient mice excrete an increased amount
Ca2 [50] of a number of low-molecular-weight plasma proteins
Drugs and toxins
in the urine [47]. This is a result of defective tubularAminoglycosides [59]
Polymyxin B [59] reabsorption as shown by the absence of immunodetect-
Aprotinin [59] able protein ligands in the proximal tubule cells of the
Trichosanthin [60]
deficient mice. Although patients with tubular dysfunc-Enzymes and enzyme-inhibitors
PAI-1 [61] tion, such as Fanconi syndrome [47, 48, 66], display some
PAI-1-urokinase [62] clinical features similar to the megalin deficient mice, no
PAI-1-tPA [41, 62]
human megalin gene defect has been described. A childProurokinase [61]
Lipoprotein lipase [63] with a possible megalin dysfunction has been reported
-amylase [25] who displays phenotypic resemblance to megalin defi-
cient mice and is dying from pulmonary complications
at the age of 19 months [67].
Cubilin also constitutes a true multiligand receptor,
protein (DBP), albumin, hemoglobin and RAP [20, 34–36]. although the number of ligands so far identified for cubi-
In the case of DBP and albumin cubilin is believed to lin is smaller than for megalin (Table 1). The ligands
further facilitate megalin-mediated endocytic uptake. expected to be present in the normal ultrafiltrate includes
DBP, albumin, hemoglobin, transferrin, Ig light chains,
Clara cell secretory protein, lipid poor apo A-I, and
LIGANDS FOR MEGALIN AND CUBILIN: HDL-3. The role of cubilin for normal tubular protein
ANIMAL AND HUMAN MODELS OF reabsorption is illustrated by the proteinuria observed
RECEPTOR DYSFUNCTION in many patients suffering from Imerslund-Gra¨sbeck
A wide variety of plasma proteins have been identified syndrome, a rare vitamin B12 deficiency disease charac-
as ligands for megalin (Table 1). Some of these, including terized by defective intestinal absorption of the intrinsic
several lipoproteins and enzymes, are normally not pres- factor-vitamin B12 (IF-B12) complex [68–70]. Two muta-
ent in the ultrafiltrate as their size prevents them from tions in the cubilin gene were identified in a subgroup
being filtered in the glomeruli. The list of filtered proteins of Finnish families with this disease: a point mutation
identified as ligands for megalin includes DBP, retinol causing one amino acid substitution in CUB domain 8
binding protein (RBP), transcobalamin (TC)-vitamin B12, affecting the binding of IF-B12 [8, 71], and a point muta-
transferrin, parathyroid hormone (PTH), transthyretin, tion believed to activate a cryptic intronic splice site caus-
ing an in-frame insertion with several stop codons andinsulin, epidermal growth factor, prolactin, albumin, he-
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predicting a truncation of the receptor in CUB domain sion of renal fibrosis simply by allowing reabsorption of
a greater amount of protein in proteinuric states. In addi-6 [71]. This diversity in mutations may explain why only
some patients with selective IF-B12 malabsorption have tion, it is interesting to note that cubilin mediates the
internalization of components that may have a direct bio-proteinuria. Mutations in the cubilin gene affecting more
binding sites or resulting in the absence of functional logical effect on proximal tubule cells. This is particularly
the case for apo A-I [32] and small HDL particles [42]receptors are more likely to give rise to proteinuria than
mutations affecting only the IF-B12 binding site. The im- reported to have mitogenic activity. It is also likely that
cubilin intervenes in transferrin-iron uptake [31] and thatportance of cubilin is further supported by the selective
proteinuria, in particular albuminuria, identified in dogs both cubilin and megalin is involved in the uptake of
hemoglobin [56], thus favoring the production of freewith a defective processing of cubilin within the epithe-
lial cells causing a vitamin-B12 malabsorption syndrome radicals. Finally, megalin may be involved in signal trans-
duction by as yet unknown pathways. Its cytoplasmic[72, 73]. Although not linked to a defect in the cubilin
gene, this dysfunction results in a functional cubilin de- domain presents NPXY motifs and Src homology 2 and
3 recognition sites and may interact with various cyto-fect both in the intestine and in the kidneys [7, 72].
The affinity of different ligands for either cubilin or plasmic adaptors and scaffold proteins. While the sig-
nificance of these interactions is not currently known, itmegalin varies from high to rather low with a dissociation
constant (Kd) ranging from the nanomolar to the micro- is suggested that megalin is not merely an endocytic
cargo receptor but could also function in the activationmolar range. The abundant expression of receptors along
the proximal tubule conceivably compensates the low of signaling in target cells [14]. Indeed, this is the case
for at least four members of the LDL receptor familyaffinity binding by constituting a high capacity system
facing the ultrafiltrate along the entire proximal tubule. (the lipoprotein receptor-related proteins 5 and 6, the
very low-density lipoprotein receptor, and the apolipo-
protein E-receptor 2) involved in the Wnt and the Reelin
PATHOPHYSIOLOGICAL IMPLICATIONS
signaling pathways and regulating key events in the cen-
OF MEGALIN AND CUBILIN MEDIATED
tral nervous system (CNS) development [76–78].
PROTEIN REABSORPTION
The large number of known ligands for cubilin and
RENAL TUBULAR UPTAKE ANDmegalin present in the proximal tubule fluid and the
METABOLISM OF CARRIER BOUND VITAMINSpresence of increased amounts of these proteins in the
Vitamin Durine of patients or animals with a deficient expression
of megalin or functional cubilin shows that cubilin and The kidney is the major organ for the final and rate-
megalin play a key role in protein reabsorption in the limiting activation of vitamin D by hydroxylation of
proximal tubule. Under physiological conditions this ac- 25(OH)-D3 to 1,25(OH)2D3. This process is compromised
tivity is beneficial in several ways. It salvages a notable in chronic renal failure, contributing to the hypocalcemia
amount of amino acids as well as physiologically impor- and hyperparathyroidism characterizing the disturbances
tant substances such as vitamins or minerals. It also may in calcium metabolism in chronic renal disease [79]. Re-
contribute to maintaining a sterile urine flow. Under cent evidence suggests that megalin and cubilin both play
pathological conditions characterized by increased glo- an important role for the renal tubular uptake of filtered
merular permeability the same property may have unde- vitamin D in complex with vitamin D-binding protein
sirable consequences. Indeed, experimental and clinical (DBP) [34, 38], suggesting that this may constitute a lim-
evidence gathered over the last 30 years shows that in- iting step for the renal synthesis of 1,25(OH)2D3. More
creased protein delivery to the proximal tubule is associ- than 80% of all serum 25(OH)D3 is associated with DBP
ated with increased protein reabsorption [reviewed in [80]. Both cubilin and megalin bind the vitamin D-DBP
[74, 75]. It was shown further that the higher the level complex with high affinity (Kd100 nmol/L) and in a
of proteinuria, the faster the development of tubulointer- calcium dependent fashion [34, 38]. Megalin deficient
stitial lesions and the progression to renal failure. The mice reveal an approximately 70% decrease in plasma
currently held hypothesis proposes that tubular protein 25(OH)D3 and 1,25(OH)2D3 [34, 38]. Similarly, dogs with
overload up-regulates vasoactive and inflammatory genes an inherited intracellular processing defect of cubilin
such as endothelin-1, monocyte chemoattractant pro- resulting in a functional cubilin deficiency display an ap-
tein-1 and chemotactic cytokine RANTES (regulated proximately 45% reduction in plasma 25(OH)D3 and an
upon activation, normal T cell expressed and secreted). approximately 59% reduction in plasma 1,25(OH)2D3
The identification of cubilin and megalin as key compo- [34]. In both cases significant amounts of DBP and vita-
nents in the reabsorption of albumin [35, 49]—the most min D metabolites are excreted in the urine. Further-
abundant plasma protein present in the proximal tubule more, megalin deficient mice reveal signs of disturbed
bone formation including growth retardation, bone de-fluid—suggests that they might play a role in the progres-
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Fig. 3. The megalin- and cubilin-mediated up-
take of three vitamin carrier protein complexes:
vitamin D binding protein (DBP)-vitamin D3,
transcobalamin (TC)-vitamin B12, and retinol
binding protein (RBP)-retinol in renal proximal
tubule. Following receptor-mediated endocyto-
sis via apical coated pits, the complexes accumu-
late in lysosomes for degradation of the pro-
teins, while the receptors recycle to the apical
plasma membrane via dense apical tubules. As
illustrated here and detailed in the text, megalin
mediates the uptake of cubilin and its ligands.
Whether the two receptors are constitutively as-
sociated in the plasma membrane and remain as-
sociated during recycling in dense apical tubules
is not known. Whereas TC and RBP apparently
bind exclusively to megalin, DBP binds with sim-
ilar affinity to both megalin and cubilin. The intra-
cellular processing of the vitamins may include
modifications such as hydroxylation of 25(OH)D3
to 1,25-(OH)2D3, and metabolism of B12. The
mechanisms for the cellular release of the vita-
mins remain to be clarified.
formation, and reduced bone density, which suggests that may bind and internalize the vitamin D-DBP complex,
this process seems to be greatly facilitated by binding ofthe associated reduction in 1,25(OH)2D3 does affect bone
metabolism [38]. Thus, a dual receptor mechanism involv- the vitamin complex to cubilin [34]. As renal function
decreases, the filtration of 25(OH)D3-DBP is reduceding both cubilin and megalin is essential to prevent urinary
loss of filtered vitamin and to provide sufficient substrate providing less substrate for the cubilin-megalin mediated
uptake and subsequent activation of vitamin D. Also,for the proximal tubule synthesis of 1,25(OH)2D3. A mech-
anism is proposed by which filtered 25(OH)D3-DBP is renal disease, particularly in the case of significant pro-
teinuria, may compromise tubular function affecting thereabsorbed in the proximal tubule by binding to cubilin
on the cell surface prior to internalization via megalin cubilin- and megalin-mediated endocytic uptake.
Mice that are deficient in DBP as a result of gene(Fig. 3). This is followed by release of 25(OH)D3 from
DBP in the endosomal compartment, translocation of disruption reveal decreased levels of 25(OH)D3 and
1,25(OH)2D3 as well as accelerated clearance and in-25(OH)D3 to the cytosol, followed by hydroxylation by
the mitochondrially bound 1-hydroxylase and secretion creased urinary excretion of injected 25(OH)[H3]-D3
[81]. This confirms that DBP is important to preventat the basolateral membrane. Although megalin itself
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loss of vitamin D in the urine and supports a role for cytic uptake of a steroid bound to its carrier protein is
different from the “free-hormone” hypothesis in whichcubilin and megalin mediated tubular uptake. Inter-
estingly, DBP deficient mice reveal biological evidence the cellular uptake of steroids is determined by the con-
centration of unbound steroid entering by diffusion [88].of vitamin D-deficiency only when put on a vitamin
D-deficient diet. This indicates that DBP-mediated up- In this context the carrier protein regulates uptake by
limiting the concentration of free steroid. The receptor-take is not the only mechanism for generating sufficient
active 1,25(OH)2D3 in mice that are continuously sup- mediated uptake of bound steroid implies the possibility
of a tissue specific, high capacity uptake for renal proxi-plied with vitamin D. An escape mechanism may involve
diffusion of free 25(OH)D3 into the tubular cells as mal tubule hydroxylation [14]. Besides the proximal tu-
bule, the 1-hydroxylase also may be expressed in distalshown in vitro [82]. Also, extrarenal activation of vitamin
D has been suggested and the 1-hydroxylase has been tubules and in cortical collecting ducts [89]. Since neither
megalin nor cubilin are located in these distal parts ofidentified in skin, placenta, lymph nodes, the intestinal
tract and other tissues [83], although the role of this the nephron, other mechanisms must account for the up-
take of vitamin into these cells. However, the proximalextrarenal 1-hydroxylase in supporting circulating lev-
els of 1,25(OH)2D3 is not established. Despite exhaustive tubule hydroxylase activity is sensitive to vitamin D-defi-
ciency and probably serves as the major source of circu-studies of DBP electrophoretic mobility in thousands of
individuals no humans have been identified who fully lating 1,25(OH)2D3 [90].
lack DBP [84, 85]. This may indicate that in contrast to
Retinol and vitamin B12mice, humans do require DBP in order to survive. A
patient with the selective vitamin B12 malabsorption syn- Other carrier bound vitamins present in plasma are
filtered in the glomeruli and reabsorbed in the proximaldrome known as Imerslund-Gra¨sbeck disease, charac-
terized by a mutation (Finnish mutation 2) in the cubilin tubule by a megalin mediated process, thus preventing
urinary loss of vitamin and possibly providing a routegene [71] causing a truncation of this receptor, as well
as three other patients with the same clinical condition for renal metabolism (Figs. 3 and 4a). These include
retinol bound to retinol-binding protein (RBP) [39] andwho are not genetically characterized, excrete elevated
amounts of DBP and 25(OH)D3 in the urine [34]. This vitamin B12 bound to transcobalamin (TC) [36, 66], the
plasma B12 binding protein important for the vitaminsuggests that cubilin mediated renal tubular uptake of
the filtered vitamin D-DBP also is of physiological sig- uptake in tissues. Both RBP-retinol and TC-B12 are fil-
tered in the glomeruli and the tubular reabsorption ofnificance in humans. Due to the limited number of pa-
tients no information on the calcium homeostasis or bone B12 is estimated as equal to the intestinal uptake [36, 91].
Both retinol-RBP and the B12-TC complexes bind toturnover in these patients was obtained; however, the
patients should express normal levels of megalin and thus megalin with high affinity [36, 39], however, in contrast to
DBP no significant binding to cubilin has been identified.should be able to reabsorb some DBP in the proximal
tubules. Patients with Fanconi syndrome may have low The urinary excretion of both retinol and RBP as well
as B12 and TC are highly elevated in megalin deficientlevels of circulating 1,25(OH)2D3 associated with osteo-
malacia [86]. This in part may be due to a defective mice [39, 66], and uptake of the vitamin complexes in
megalin expressing cells in vitro and in proximal tubulemegalin- and cubilin-mediated tubular uptake of vitamin
D-DBP, as it has been shown that these patients often cells in vivo is inhibited by RAP and anti-megalin anti-
bodies, as well as in megalin deficient animals (Fig. 4 b, c)have low molecular weight proteinuria.
Megalin also may affect calcium homeostasis differ- [36, 39, 92, 93]. Transthyretin, a plasma carrier of both
RBP and thyroxine, also binds to megalin [48]. Similarently from its role in vitamin D metabolism. It has been
shown that megalin in the proximal tubules binds and to RBP, proximal tubule uptake of transthyretin is defec-
tive in megalin deficient mice causing elevated urinarymediates the lysosomal degradation of PTH as this hor-
mone is filtered in the glomeruli [45]. In mouse F9 em- excretion of this protein. Thus, although transthyretin is
believed to limit filtration of bound holo-RBP [94], itbryonal carcinoma cells with an induced expression of
both the PTH/PTHrP-receptor and megalin, inhibition does appear to be filtered to some extent and is reab-
sorbed in the proximal tubule by binding to the sameof megalin-mediated uptake of PTH caused an increase
in PTH-stimulated cAMP production. Thus, megalin receptor as RBP.
Patients with Dent’s disease caused by mutations inmay antagonize the effect of PTH on the luminally ex-
pressed PTH/PTHrP-receptor in the kidney proximal the ClC-5 chloride transporter gene and possibly associ-
ated with a decreased expression of megalin [95, 96] havetubules by removing the hormone from the filtrate [45].
In addition, megalin is expressed on the parathyroid cells increased urinary excretion of TC [66], indicating that
filtered TC-B12 is normally reabsorbed and supportingand may as a calcium binding protein serve as a potential
calcium sensor [87]. the notion that renal tubular uptake in humans prevents
the loss of vitamins.The concept of the cubilin-megalin mediated endo-
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The role of the kidney in retinol or B12 homeostasis
is not clarified. Megalin deficient mice are low in serum
levels of B12 and show greatly reduced levels of vitamin
within the kidney [66]. Furthermore, in rodents a large
accumulation of B12 in the kidney has been observed in
vitamin loaded animals [66, 97–99]. This accumulation
is very sensitive to changes in vitamin status. Both in
vivo and in vitro the kidney cells are able to metabolize
much of the reabsorbed vitamin B12 (abstract; Nielsen
et al, J Am Soc Nephrol 12:59A, 2001). This suggests a
role of the kidney in vitamin B12 homeostasis, as indicated
by some studies showing a reduction in the hyperhomo-
cysteinemia often associated with end-stage renal disease
by B12 supplementation [100, 101]. Yet, the association
between vitamin deficiency and kidney disease remains
to be established.
Interestingly, cubilin constitutes the intestinal receptor
for IF-B12 mediating the intestinal uptake of ingested vi-
tamin [37]. However, since no or at the most only neglig-
ible amounts of intrinsic factor are present in plasma
[102], cubilin-mediated renal uptake of IF-B12 is insignif-
icant. Thus, whereas defective intestinal uptake may con-
tribute to low levels of serum B12 in megalin deficient mice,
it does not account for the increased urinary clearance or
the low renal vitamin content, suggesting an important
role for megalin in recovering filtered TC-B12 [66].
Transtubular transport of vitamins
The mechanism for renal tubular transcytosis of vita-
mins is largely unknown (Fig. 3). Although recent evi-
dence suggests transcytosis of intact RBP in vitro [103],
Fig. 4. Confocal fluorescent immunocytochemistry showing the expres-
sion of megalin and megalin mediated uptake of TC and B12 in rabbit
and mouse kidney cortex. (a) Expression of megalin (sheep anti-rat
megalin, blue fluorescence), and megalin mediated uptake of TC (guinea
pig anti-rabbit TC, green fluorescence) and B12 (mouse anti-B12, red
fluorescence) in rabbit kidney cortex. Megalin is expressed in the brush
border of proximal tubules. Filtered TC and B12 are internalized into
vesicular structures by megalin mediated endocytosis. In early endo-
somal structures B12 is bound to TC and thus not recognized by the
anti-B12 antibody (vesicles labeled by green fluorescence only). In late
endosomes TC and B12 dissociate and both are recognized by antibodies
giving rise to double labeling showing as yellow colored vesicles (ar-
rows). In lysosomes TC is degraded whereas B12 seems to accumulate
in this compartment [66], as indicated by the red fluorescence (arrow-
heads). (b) Expression of megalin (rabbit anti-rat megalin, red fluores-
cence) and B12 (sheep anti-B12, green fluorescence) in mouse kidney
cortex. Megalin is expressed in the brush border of proximal tubules
and endocytosed vitamin B12 can be identified in vesicular structures
in some, but not all proximal tubule profiles. Most filtered TC-B12 appear
to be reabsorbed within the very first part of the proximal tubules [66].
(c) Expression of megalin (rabbit anti-rat megalin, red fluorescence) and
B12 (sheep anti-B12, green fluorescence, arrowheads) in kidney cortex of
megalin deficient mice. Neither megalin nor B12 can be identified in
proximal tubules (P), suggesting an important role of megalin for the
uptake of B12. P* indicates a proximal tubule profile representing the
very first part of the proximal tubule as it can be seen to originate from
the urinary pole of a glomerulus. Bars represent 16 m.
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transcellular transport of intact protein in general is in- MEGALIN EXPRESSION IN KIDNEY DISEASE
significant in the proximal tubule [104]. Thus, it has been Decrease in megalin expression has been described in
hypothesized that the endocytosed vitamin is released various types of renal disease. Dent’s disease, which is
from its carrier protein, which is then degraded within due to a mutation of the chloride gated channel ClC-5,
the endosomal or lysosomal compartment [39]. Vitamins is characterized by a generalized dysfunction of the prox-
(including vitamin D) that are metabolized within the imal convoluted tubule (Fanconi syndrome) manifested
by amino-aciduria, glycosuria, hypercalciuria and lowtubular cells are then translocated to the cytoplasm and
molecular weight proteinuria [48]. The potential involve-secreted at the basolateral membrane. The vitamin may
ment of megalin was first suggested when the ClC-5/be secreted in a complex with newly synthesized carrier
mice were reported to develop low molecular weightprotein or as free vitamin that is then coupled to apopro-
proteinuria and decreased expression of megalin [95,teins in plasma. Using a proximal tubule cell line it has
122], but the exact mechanisms are far from understood.been shown in vitro that endocytosis of TC-B12 is fol-
The ability of megalin to associate with the Na/Hlowed by degradation of TC and release of B12 from
exchange-3 (NHE-3) isoform of the Na/H transporterthe cells in complex with newly synthesized proteins,
is of potential interest in this context since there is evi-including TC and haptocorrin, another B12 binding pro-
dence that the absence of ClC-5 prevents the establish-tein present in plasma and various body secretions [93,
ment of the electrical shunt required for the function of105]. This is consistent with the identification of TC
the Na/H transporter [123]. It is believed that thismRNA in the kidney from various species [93, 106].
results in a failure to acidify some of the endosomal
The extrarenal expression of both megalin and cubilin
compartments of the proximal tubule cells that may in
suggests that these receptors may serve an extended nu- turn result in a general defect in tubular endocytosis
tritional function responsible for the uptake of vitamins through undefined pathways, possibly involving abnor-
in vital organs such as the yolk sac [11] and possibly the mal membrane recycling. The decreased amount of meg-
brain. This may be among the possible causes of the alin present in the urine of Dent’s patients [96] is compat-
multiple defects characterizing the megalin deficient ible with this hypothesis. One should note, however, that
phenotype and of the teratogenic effects of anti-cubilin the Fanconi syndrome occurs in different contexts in
antibodies injected into pregnant rats [19]. which megalin expression may not be altered.
In addition, reduced megalin expression was reported
in a rat model of autosomal-dominant polycystic kidney
MEGALIN MEDIATED NEPHROTOXICITY disease [124]. Decrease in megalin expression also has
been observed in vitro following incubation with theMegalin is involved in the proximal tubule uptake of
plant toxin aristolochic acid, indicating a role in the earlyvarious non-protein nephrotoxic substances including
proximal tubule dysfunction, including low molecularaminoglycosides, polymyxin B [59, 107, 108], as well as
weight proteinuria, observed in aristolochic acid nephro-the plant-derived ribosome inactivating agent tricho-
toxicity [125].santhin [60]. The mechanism of aminoglycoside nephro-
toxicity has not been fully elucidated, however, several
studies suggest that the initial step involves endocytic CONCLUSION
uptake of the aminoglycosides in proximal tubule cells Cubilin and megalin are interacting high molecular
[109–117]. Although binding of aminoglycosides to phos- weight receptors massively expressed by the apical endo-
pholipids in the apical plasma membranes has been im- cytic apparatus of epithelial cells of the renal proximal
plicated [118–120], the specific accumulation of amino- tubule. Their characterization, both structural and func-
glycosides in the kidney proximal tubule suggests the tional as multiligand receptors, has allowed us to under-
stand at least part of the mechanism involved in proteinpresence of a specific uptake mechanism most likely in-
reabsorption in the proximal tubule. Our understandingvolving megalin. Gentamicin, netilimicin, and amikacin
of their properties has provided new insight in the roleas well as polymyxin B have been shown to bind to meg-
of the kidney to preserve and metabolize nutrients suchalin mediating the uptake of these drugs in vitro as well
as vitamins and established a new mode of entry of lipo-as in proximal tubule cells in vivo and the affinity for
soluble vitamins in proximal tubule cells. In addition, bybinding to megalin is higher than that for binding to
mediating the uptake of excessively filtered proteins thephospholipids [59]. Furthermore, renal endocytic uptake
receptors may play a key role in the initial steps leadingof aminoglycosides correlates with renal megalin activity
to renal disease progression.
and is abolished in megalin deficient mice [108]. Interest-
Reprint requests to Erik Ilsø Christensen, M.D., Ph.D., Departmentingly, megalin also is expressed in the inner ear, in partic-
of Cell Biology, Institute of Anatomy, University of Aarhus, Universityular the strial marginal cells, which are sensitive to Park, Building 234, DK-8000 Aarhus C, Denmark.
E-mail: eic@ana.au.dkaminoglycosides [121].
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